Valeria Rudman-Melnick1, Mike Adam1, Andrew Potter1, Saagar M Chokshi2, Qing Ma2, Keri A Drake3, Meredith P Schuh2, J Matthew Kofron1, Prasad Devarajan2, S Steven Potter4. 1. Division of Developmental Biology, Cincinnati Children's Medical Center, Cincinnati, Ohio. 2. Division of Nephrology and Hypertension, Cincinnati Children's Medical Center, Cincinnati, Ohio. 3. Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas. 4. Division of Developmental Biology, Cincinnati Children's Medical Center, Cincinnati, Ohio Steve.Potter@cchmc.org.
Abstract
BACKGROUND: Current management of AKI, a potentially fatal disorder that can also initiate or exacerbate CKD, is merely supportive. Therefore, deeper understanding of the molecular pathways perturbed in AKI is needed to identify targets with potential to lead to improved treatment. METHODS: We performed single-cell RNA sequencing (scRNA-seq) with the clinically relevant unilateral ischemia-reperfusion murine model of AKI at days 1, 2, 4, 7, 11, and 14 after AKI onset. Using real-time quantitative PCR, immunofluorescence, Western blotting, and both chromogenic and single-molecule in situ hybridizations, we validated AKI signatures in multiple experiments. RESULTS: Our findings show the time course of changing gene expression patterns for multiple AKI stages and all renal cell types. We observed elevated expression of crucial injury response factors-including kidney injury molecule-1 (Kim1), lipocalin 2 (Lcn2), and keratin 8 (Krt8)-and of several novel genes (Ahnak, Sh3bgrl3, and Col18a1) not previously examined in kidney pathologies. AKI induced proximal tubule dedifferentiation, with a pronounced nephrogenic signature represented by Sox4 and Cd24a. Moreover, AKI caused the formation of "mixed-identity cells" (expressing markers of different renal cell types) that are normally seen only during early kidney development. The injured tubules acquired a proinflammatory and profibrotic phenotype; moreover, AKI dramatically modified ligand-receptor crosstalk, with potential pathologic epithelial-to-stromal interactions. Advancing age in AKI onset was associated with maladaptive response and kidney fibrosis. CONCLUSIONS: The scRNA-seq, comprehensive, cell-specific profiles provide a valuable resource for examining molecular pathways that are perturbed in AKI. The results fully define AKI-associated dedifferentiation programs, potential pathologic ligand-receptor crosstalk, novel genes, and the improved injury response in younger mice, and highlight potential targets of kidney injury.
BACKGROUND: Current management of AKI, a potentially fatal disorder that can also initiate or exacerbate CKD, is merely supportive. Therefore, deeper understanding of the molecular pathways perturbed in AKI is needed to identify targets with potential to lead to improved treatment. METHODS: We performed single-cell RNA sequencing (scRNA-seq) with the clinically relevant unilateral ischemia-reperfusion murine model of AKI at days 1, 2, 4, 7, 11, and 14 after AKI onset. Using real-time quantitative PCR, immunofluorescence, Western blotting, and both chromogenic and single-molecule in situ hybridizations, we validated AKI signatures in multiple experiments. RESULTS: Our findings show the time course of changing gene expression patterns for multiple AKI stages and all renal cell types. We observed elevated expression of crucial injury response factors-including kidney injury molecule-1 (Kim1), lipocalin 2 (Lcn2), and keratin 8 (Krt8)-and of several novel genes (Ahnak, Sh3bgrl3, and Col18a1) not previously examined in kidney pathologies. AKI induced proximal tubule dedifferentiation, with a pronounced nephrogenic signature represented by Sox4 and Cd24a. Moreover, AKI caused the formation of "mixed-identity cells" (expressing markers of different renal cell types) that are normally seen only during early kidney development. The injured tubules acquired a proinflammatory and profibrotic phenotype; moreover, AKI dramatically modified ligand-receptor crosstalk, with potential pathologic epithelial-to-stromal interactions. Advancing age in AKI onset was associated with maladaptive response and kidney fibrosis. CONCLUSIONS: The scRNA-seq, comprehensive, cell-specific profiles provide a valuable resource for examining molecular pathways that are perturbed in AKI. The results fully define AKI-associated dedifferentiation programs, potential pathologic ligand-receptor crosstalk, novel genes, and the improved injury response in younger mice, and highlight potential targets of kidney injury.
Authors: Honglei Huang; Leon F A van Dullemen; Mohammed Z Akhtar; Maria-Letizia Lo Faro; Zhanru Yu; Alessandro Valli; Anthony Dona; Marie-Laëtitia Thézénas; Philip D Charles; Roman Fischer; Maria Kaisar; Henri G D Leuvenink; Rutger J Ploeg; Benedikt M Kessler Journal: Sci Rep Date: 2018-06-04 Impact factor: 4.379
Authors: Parker C Wilson; Haojia Wu; Yuhei Kirita; Kohei Uchimura; Nicolas Ledru; Helmut G Rennke; Paul A Welling; Sushrut S Waikar; Benjamin D Humphreys Journal: Proc Natl Acad Sci U S A Date: 2019-09-10 Impact factor: 11.205
Authors: Xiaojia Guo; Leyuan Xu; Heino Velazquez; Tian-Min Chen; Ryan M Williams; Daniel A Heller; Barbara Burtness; Robert Safirstein; Gary V Desir Journal: J Am Soc Nephrol Date: 2021-12-17 Impact factor: 10.121
Authors: Ian Vargas; Daniel J Stephenson; Margaret Baldwin; Joseph P Gaut; Charles E Chalfant; Hua Pan; Samuel A Wickline Journal: Nanomedicine Date: 2021-07-23 Impact factor: 5.307
Authors: Louisa M S Gerhardt; Jing Liu; Kari Koppitch; Pietro E Cippà; Andrew P McMahon Journal: Proc Natl Acad Sci U S A Date: 2021-07-06 Impact factor: 11.205